Jonathan Ducore

Title(s)Professor, Pediatrics
SchoolSchool of Veterinary Medicine
AddressTicon I
CA 95817
Phone916-734-2781
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Long-term efficacy and safety of damoctocog alfa pegol prophylaxis in patients with haemophilia A aged 12-<18 years at enrolment into PROTECT VIII. Acta Haematol. 2024 Apr 10. Reding MT, Simpson M, Ducore J, Holme PA, Maas Enriquez M, Mancuso ME. PMID: 38599195.
      View in: PubMed   Mentions:    Fields:    
    2. Medical imaging utilization and associated radiation exposure in children with down syndrome. PLoS One. 2023; 18(9):e0289957. Marlow EC, Ducore JM, Kwan ML, Bowles EJA, Greenlee RT, Pole JD, Rahm AK, Stout NK, Weinmann S, Smith-Bindman R, Miglioretti DL. PMID: 37672503; PMCID: PMC10482278.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    3. Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect study. Eur J Haematol. 2023 Oct; 111(4):544-552. Mathias M, Abraham A, Belletrutti MJ, Carcao M, Carvalho M, Chambost H, Chan AKC, Dubey L, Ducore J, Gattens M, Gresele P, Gruel Y, Guillet B, Jiménez-Yuste V, Kitanovski L, Klukowska A, Lohade S, Mancuso ME, Oldenburg J, Pollio B, Sigaud M, Vilchevska K, Wu JKM, Jansen M, Belyanskaya L, Walter O, Knaub S, Neufeld EJ. PMID: 37439123.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Long-term immunogenicity, efficacy and tolerability of simoctocog alfa in patients with severe haemophilia A who had completed the NuProtect study in previously untreated patients. Haemophilia. 2023 Jul; 29(4):1005-1012. Mathias M, Abashidze M, Abraham A, Belletrutti MJ, Carcao M, Chambost H, Chan AKC, Dubey L, Ducore J, Lambert T, Kavardakova N, Lohade S, Turea V, Wu JKM, Klukowska A. PMID: 37335546.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    5. Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors. Haemophilia. 2022 Jul; 28(4):548-556. Pipe SW, Hermans C, Chitlur M, Carcao M, Castaman G, Davis JA, Ducore J, Dunn AL, Escobar M, Journeycake J, Khan O, Mahlangu J, Meeks SL, Mitha IH, Négrier C, Nowak-Göttl U, Recht M, Chrisentery-Singleton T, Stasyshyn O, Vilchevska KV, Martinez LV, Wang M, Windyga J, Young G, Alexander WA, Bonzo D, Macie C, Mitchell IS, Sauty E, Wilkinson TA, Shapiro AD. PMID: 35475308; PMCID: PMC9542908.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    6. The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors. Haemophilia. 2021 Nov; 27(6):921-931. Escobar M, Castaman G, Boix SB, Callaghan M, de Moerloose P, Ducore J, Hermans C, Journeycake J, Leissinger C, Luck J, Mahlangu J, Miesbach W, Mitha IH, Négrier C, Quon D, Recht M, Schved JF, Shapiro AD, Sidonio R, Srivastava A, Stasyshyn O, Vilchevska KV, Wang M, Young G, Alexander WA, Al-Sabbagh A, Bonzo D, Macie C, Wilkinson TA, Kessler C. PMID: 34636112; PMCID: PMC9292935.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    7. PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors. Haemophilia. 2021 Nov; 27(6):911-920. Escobar M, Luck J, Averianov Y, Ducore J, Fernández MFL, Giermasz A, Hart DP, Journeycake J, Kessler C, Leissinger C, Mahlangu J, Martinez LV, Miesbach W, Mitha IH, Quon D, Reding MT, Schved JF, Stasyshyn O, Vilchevska KV, Wang M, Windyga J, Alexander WA, Al-Sabbagh A, Bonzo D, Mitchell IS, Wilkinson TA, Hermans C. PMID: 34614267; PMCID: PMC9292306.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    8. Assessing Safe Discharge Criteria for Pediatric Oncology Patients Admitted for Febrile Neutropenia. J Pediatr Hematol Oncol. 2021 08 01; 43(6):e880-e885. Huschart E, Ducore J, Chung J. PMID: 33625079.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Safety and efficacy of BAY 94-9027, an extended-half-life factor VIII, during minor surgical procedures in patients with severe haemophilia A. Haemophilia. 2021 Jul; 27(4):e559-e562. Santagostino E, Lalezari S, Reding MT, Ducore J, Ng HJ, Poulsen LH, Michaels LA, Linardi C. PMID: 33939226.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    10. Leukemia Risk in a Cohort of 3.9 Million Children with and without Down Syndrome. J Pediatr. 2021 Jul; 234:172-180.e3. Marlow EC, Ducore J, Kwan ML, Cheng SY, Bowles EJA, Greenlee RT, Pole JD, Rahm AK, Stout NK, Weinmann S, Smith-Bindman R, Miglioretti DL. PMID: 33684394; PMCID: PMC8238875.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    11. Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study. Thromb Haemost. 2021 Nov; 121(11):1400-1408. Liesner RJ, Abraham A, Altisent C, Belletrutti MJ, Carcao M, Carvalho M, Chambost H, Chan AKC, Dubey L, Ducore J, Gattens M, Gresele P, Gruel Y, Guillet B, Jimenez-Yuste V, Kitanovski L, Klukowska A, Lohade S, Mancuso ME, Oldenburg J, Pavlova A, Pollio B, Sigaud M, Vdovin V, Vilchevska K, Wu JKM, Jansen M, Belyanskaya L, Walter O, Knaub S, Neufeld EJ. PMID: 33581698; PMCID: PMC8570909.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    12. Modelling future usage and cost of factor and emicizumab to treat haemophilia A for the US Western States Region IX haemophilia treatment centres. Haemophilia. 2021 Jan; 27(1):e22-e29. Stonebraker JS, Ducore JM. PMID: 33012106.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Safety and efficacy of BAY 94-9027, an extended-half-life factor VIII, during surgery in patients with severe hemophilia A: Results of the PROTECT VIII clinical trial. Thromb Res. 2019 Nov; 183:13-19. Santagostino E, Lalezari S, Reding MT, Ducore J, Ng HJ, Poulsen LH, Michaels LA, Linardi CCG. PMID: 31513978.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    14. A novel approach to immune tolerance induction in haemophilia A with factor VIII inhibitor. Haemophilia. 2019 01; 25(1):e48-e50. Thornburg CD, Ducore J. PMID: 30468284.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant. N Engl J Med. 2017 12 07; 377(23):2215-2227. George LA, Sullivan SK, Giermasz A, Rasko JEJ, Samelson-Jones BJ, Ducore J, Cuker A, Sullivan LM, Majumdar S, Teitel J, McGuinn CE, Ragni MV, Luk AY, Hui D, Wright JF, Chen Y, Liu Y, Wachtel K, Winters A, Tiefenbacher S, Arruda VR, van der Loo JCM, Zelenaia O, Takefman D, Carr ME, Couto LB, Anguela XM, High KA. PMID: 29211678; PMCID: PMC6029626.
      View in: PubMed   Mentions: 305     Fields:    Translation:HumansCellsCTClinical Trials
    16. Safety and dose-dependency of eptacog beta (activated) in a dose escalation study of non-bleeding congenital haemophilia A or B patients, with or without inhibitors. Haemophilia. 2017 Nov; 23(6):844-851. Ducore J, Lawrence JB, Simpson M, Boggio L, Bellon A, Burggraaf J, Stevens J, Moerland M, Frieling J, Reijers J, Wang M. PMID: 28984010.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    17. Primary Renal Lymphoma Presenting as End-Stage Renal Disease. Case Rep Med. 2017; 2017:9210648. Butani L, Ducore J. PMID: 29098007; PMCID: PMC5642876.
      View in: PubMed   Mentions: 5  
    18. Immunogenicity, efficacy and safety of Nuwiq® (human-cl rhFVIII) in previously untreated patients with severe haemophilia A-Interim results from the NuProtect Study. Haemophilia. 2018 Mar; 24(2):211-220. Liesner RJ, Abashidze M, Aleinikova O, Altisent C, Belletrutti MJ, Borel-Derlon A, Carcao M, Chambost H, Chan AKC, Dubey L, Ducore J, Fouzia NA, Gattens M, Gruel Y, Guillet B, Kavardakova N, El Khorassani M, Klukowska A, Lambert T, Lohade S, Sigaud M, Turea V, Wu JKM, Vdovin V, Pavlova A, Jansen M, Belyanskaya L, Walter O, Knaub S, Neufeld EJ. PMID: 28815880.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCTClinical Trials
    19. PERSEPT 1: a phase 3 trial of activated eptacog beta for on-demand treatment of haemophilia inhibitor-related bleeding. Haemophilia. 2017 Nov; 23(6):832-843. Wang M, Lawrence JB, Quon DV, Ducore J, Simpson ML, Boggio LN, Mitchell IS, Yuan G, Alexander WA, Schved JF. PMID: 28776894.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    20. End-Stage Renal Disease From Cast Nephropathy in a Teenager With Neuroendocrine Carcinoma. J Pediatr Hematol Oncol. 2016 07; 38(5):e177-9. Butani L, Ducore J. PMID: 26989910.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    21. Prospective, multicenter study of postoperative deep-vein thrombosis in patients with haemophilia undergoing major orthopaedic surgery. Thromb Haemost. 2016 07 04; 116(1):42-9. Buckner TW, Leavitt AD, Ragni M, Kempton CL, Eyster ME, Cuker A, Lentz SR, Ducore J, Leissinger C, Wang M, Key NS. PMID: 27009484.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    22. Dust metal loadings and the risk of childhood acute lymphoblastic leukemia. J Expo Sci Environ Epidemiol. 2015 Nov-Dec; 25(6):593-8. Whitehead TP, Ward MH, Colt JS, Dahl G, Ducore J, Reinier K, Gunier RB, Katharine Hammond S, Rappaport SM, Metayer C. PMID: 25736162; PMCID: PMC4560677.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    23. Alprolix (recombinant Factor IX Fc fusion protein): extended half-life product for the prophylaxis and treatment of hemophilia B. Expert Rev Hematol. 2014 Oct; 7(5):559-71. Ducore JM, Miguelino MG, Powell JS. PMID: 25142322.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    24. WARM N COLD: malignant and benign renal tumors in children. Emerg Radiol. 2014 Jun; 21(3):261-9. Sanchez TR, Ducore J, Balagtas J, Molloy C, Wootton-Gorges SL. PMID: 24570120.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    25. Children and adolescents with ALL are taller than expected at diagnosis. J Pediatr Hematol Oncol. 2014 Jan; 36(1):16-21. Huang T, Ducore JM. PMID: 23799523.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    26. Tobacco smoke exposure and the risk of childhood acute lymphoblastic and myeloid leukemias by cytogenetic subtype. Cancer Epidemiol Biomarkers Prev. 2013 Sep; 22(9):1600-11. Metayer C, Zhang L, Wiemels JL, Wiemels JL, Bartley K, Schiffman J, Ma X, Aldrich MC, Chang JS, Selvin S, Fu CH, Ducore J, Smith MT, Buffler PA. PMID: 23853208; PMCID: PMC3769478.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansPHPublic Health
    27. Oral or parenteral administration of curcumin does not prevent the growth of high-risk t(4;11) acute lymphoblastic leukemia cells engrafted into a NOD/SCID mouse model. Int J Oncol. 2013 Feb; 42(2):741-8. Zunino SJ, Storms DH, Newman JW, Pedersen TL, Keen CL, Ducore JM. PMID: 23232667; PMCID: PMC3583839.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    28. Dietary resveratrol does not delay engraftment, sensitize to vincristine or inhibit growth of high-risk acute lymphoblastic leukemia cells in NOD/SCID mice. Int J Oncol. 2012 Dec; 41(6):2207-12. Zunino SJ, Storms DH, Newman JW, Pedersen TL, Keen CL, Ducore JM. PMID: 23041950; PMCID: PMC3583654.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    29. Resveratrol given intraperitoneally does not inhibit the growth of high-risk t(4;11) acute lymphoblastic leukemia cells in a NOD/SCID mouse model. Int J Oncol. 2012 Apr; 40(4):1277-84. Zunino SJ, Storms DH, Newman JW, Pedersen TL, Keen CL, Ducore JM. PMID: 22200740; PMCID: PMC3270126.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    30. Thrombotic thrombocytopenic purpura in a child with systemic lupus erythematosus. J Pediatr Hematol Oncol. 2011 Apr; 33(3):221-3. Thampi S, Salmi D, Imashuku S, Ducore J, Satake N. PMID: 21336165.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    31. Parthenolide treatment activates stress signaling proteins in high-risk acute lymphoblastic leukemia cells with chromosomal translocation t(4;11). Int J Oncol. 2010 Nov; 37(5):1307-13. Zunino SJ, Storms DH, Ducore JM. PMID: 20878078.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    32. Diagnostic X-rays and risk of childhood leukaemia. Int J Epidemiol. 2010 Dec; 39(6):1628-37. Bartley K, Metayer C, Selvin S, Ducore J, Buffler P. PMID: 20889538; PMCID: PMC2992630.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansPHPublic Health
    33. Novel in vivo model of inducible multi-drug resistance in acute lymphoblastic leukemia with chromosomal translocation t(4;11). Cancer Lett. 2010 Oct 01; 296(1):49-54. Zunino SJ, Storms DH, Ducore JM. PMID: 20381955; PMCID: PMC2906616.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    34. Bleeding symptoms and laboratory correlation in patients with severe von Willebrand disease. Haemophilia. 2009 Jul; 15(4):918-25. Metjian AD, Wang C, Sood SL, Cuker A, Peterson SM, Soucie JM, Konkle BA, HTCN Study Investigators. PMID: 19473418.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    35. Risk factors for the development of obesity in children surviving ALL and NHL. J Pediatr Hematol Oncol. 2009 Feb; 31(2):101-7. Gofman I, Ducore J. PMID: 19194192.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    36. Parthenolide induces significant apoptosis and production of reactive oxygen species in high-risk pre-B leukemia cells. Cancer Lett. 2007 Aug 28; 254(1):119-27. Zunino SJ, Ducore JM, Storms DH. PMID: 17470383.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    37. Rhabdomyoblastic pulmonary lesions in a patient with Wilms tumor: choristomas or metastases? Pediatr Blood Cancer. 2006 Mar; 46(3):381-4. Zwerdling T, Ducore J, Taylor D, West DC, Konia T. PMID: 15926167.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    38. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296. Pediatr Blood Cancer. 2006 Feb; 46(2):179-86. Winter SS, Holdsworth MT, Devidas M, Raisch DW, Chauvenet A, Ravindranath Y, Ducore JM, Amylon MD. PMID: 16007607.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    39. Breastfeeding patterns and risk of childhood acute lymphoblastic leukaemia. Br J Cancer. 2005 Aug 08; 93(3):379-84. Kwan ML, Buffler PA, Wiemels JL, Metayer C, Selvin S, Ducore JM, Block G. PMID: 16052219; PMCID: PMC2361562.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    40. Cancer occurrence in Southeast Asian children in California. J Pediatr Hematol Oncol. 2004 Oct; 26(10):613-8. Ducore JM, Parikh-Patel A, Gold EB. PMID: 15454830.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    41. Cancer Occurrence in Southeast Asian Children in California. J Pediatr Hematol Oncol. 2004 Oct; 26(10):613-618. Ducore JM, Parikh-Patel A, Gold EB. PMID: 27811600.
      View in: PubMed   Mentions:    Fields:    
    42. The North American Immune Tolerance Registry: practices, outcomes, outcome predictors. Thromb Haemost. 2002 Jan; 87(1):52-7. DiMichele DM, Kroner BL, North American Immune Tolerance Study Group. PMID: 11848456.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansPHPublic Health
    43. Surveillance neuroimaging to detect relapse in childhood brain tumors: a Pediatric Oncology Group study. J Clin Oncol. 2001 Nov 01; 19(21):4135-40. Minn AY, Pollock BH, Garzarella L, Dahl GV, Kun LE, Ducore JM, Shibata A, Kepner J, Fisher PG. PMID: 11689581.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    44. Paraparesis, hypermanganesaemia, and polycythaemia: a novel presentation of cirrhosis. Arch Dis Child. 2000 Nov; 83(5):439-42. Gospe SM, Caruso RD, Clegg MS, Keen CL, Pimstone NR, Ducore JM, Gettner SS, Kreutzer RA. PMID: 11040156; PMCID: PMC1718535.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    45. Oral methotrexate for recurrent brain tumors in children: a Pediatric Oncology Group study. J Pediatr Hematol Oncol. 2000 Jan-Feb; 22(1):41-4. Mulne AF, Ducore JM, Elterman RD, Friedman HS, Krischer JP, Kun LE, Shuster JJ, Kadota RP. PMID: 10695820.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    46. Bone marrow transplant in thalassemia. A role for radiation? Ann N Y Acad Sci. 1998 Jun 30; 850:503-5. Lee YS, Kristovich KM, Ducore JM, Vichinsky E, Crouse VL, Glader BE, Amylon MD. PMID: 9668596.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    47. Hydrogen peroxide induces DNA single strand breaks in respiratory epithelial cells. Inflammation. 1993 Dec; 17(6):715-22. McDonald RJ, Pan LC, St George JA, Hyde DM, Ducore JM. PMID: 8112830.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    48. Air bags: trade-offs. N Engl J Med. 1991 Nov 21; 325(21):1518-9. Rosenblatt M, Freilich B, Kirsch D. PMID: 1944435.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    49. A DNA crosslinking drug alters synthesis of several low molecular weight proteins in human lymphoma cells. Biochem Biophys Res Commun. 1991 Apr 30; 176(2):717-21. Widstrom RL, Ducore JM. PMID: 2025284.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    50. High-dose cytarabine for intensification of early therapy of childhood acute myeloid leukemia: a Pediatric Oncology Group study. J Clin Oncol. 1991 Apr; 9(4):572-80. Ravindranath Y, Steuber CP, Krischer J, Civin CI, Ducore J, Vega R, Pitel P, Inoue S, Bleher E, Sexauer C, et al. PMID: 2066754.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    51. Bone pain as an initial symptom of childhood acute lymphoblastic leukemia: association with nearly normal hematologic indexes. J Pediatr. 1990 Aug; 117(2 Pt 1):233-7. Jonsson OG, Sartain P, Ducore JM, Buchanan GR. PMID: 2380822.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    52. Relationship between life expectancy and endogenous DNA single-strand breakage, strand break induction and DNA repair capacity in the adult housefly, Musca domestica. Mech Ageing Dev. 1989 Sep; 49(3):259-70. Newton RK, Ducore JM, Sohal RS. PMID: 2682059.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    53. DNA-protein crosslinking in normal and solar UV-sensitive ICR 2A frog cell lines exposed to solar UV-radiation. Mutat Res. 1989 May; 217(3):219-26. Rosenstein BS, Lai LW, Ducore JM, Rosenstein RB. PMID: 2716758.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    54. Effect of age on endogenous DNA single-strand breakage, strand break induction and repair in the adult housefly, Musca domestica. Mutat Res. 1989 Mar; 219(2):113-20. Newton RK, Ducore JM, Sohal RS. PMID: 2927416.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    55. Cytotoxicity and DNA damage caused by the azoxy metabolites of procarbazine in L1210 tumor cells. Cancer Res. 1989 Jan 01; 49(1):127-33. Erikson JM, Tweedie DJ, Ducore JM, Prough RA. PMID: 2908840.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    56. Medically inappropriate hospital use in a pediatric population. N Engl J Med. 1988 Oct 06; 319(14):953. PMID: 3419464.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    57. EDTA alkaline elution characteristics and measurement of DNA damage in unlabeled DNA using Hoechst 33258 fluorescence. Environ Mol Mutagen. 1988; 11(4):449-60. Ducore JM. PMID: 2453357.
      View in: PubMed   Mentions: 1     Fields:    Translation:Cells
    58. DNA-protein crosslinking in normal human skin fibroblasts exposed to solar ultraviolet wavelengths. Photochem Photobiol. 1987 Jul; 46(1):143-6. Lai LW, Ducore JM, Rosenstein BS. PMID: 3615631.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    59. alpha-Difluoromethylornithine effects on nitrosourea-induced cytotoxicity and crosslinking in a methylation excision repair positive (MER+) human cell line. Biochem Pharmacol. 1987 Jul 01; 36(13):2169-74. Ducore JM. PMID: 3111477.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    60. Effect of alpha-difluoromethylornithine on L-phenylalanine mustard-induced cytotoxicity and DNA interstrand cross-linking in a human cell line in vitro. Cancer Res. 1986 Mar; 46(3):1068-72. Ducore JM, McNamara L. PMID: 3080230.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    61. cis-Diamminedichloroplatinum(II) (DDP)-induced crosslinking and crosslink removal in L1210 cells in vitro after theophylline co-treatment. Biochem Pharmacol. 1986 Feb 15; 35(4):607-11. Ducore JM. PMID: 3947390.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    62. The use of metabolic inhibitors to compare the excision repair of pyrimidine dimers and nondimer DNA damages in human skin fibroblasts exposed to 254-nm and sunlamp-produced greater than 310-nm ultraviolet radiation. Environ Mutagen. 1986; 8(3):335-43. Rosenstein BS, Chao CC, Ducore JM. PMID: 3709422.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    63. Use of a highly sensitive assay to analyze the excision repair of dimer and nondimer DNA damages induced in human skin fibroblasts by 254-nm and solar ultraviolet radiation. Cancer Res. 1985 Nov; 45(11 Pt 1):5526-31. Rosenstein BS, Murphy JT, Ducore JM. PMID: 4053026.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    64. Analysis of the excision repair of nondimer DNA damage induced by solar ultraviolet radiation in ICR 2A frog cells. Radiat Res. 1985 Aug; 103(2):286-92. Rosenstein BS, Chao CC, Ducore JM. PMID: 3875117.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    65. Theophylline release of replicon initiation inhibition by nitrosoureas correlates with the synergistic killing in L1210 leukemia in vitro. Mutat Res. 1985 Jul; 146(1):1-8. Ducore JM, Rosenstein BS. PMID: 4000148.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    66. Theophylline reversal of alkylator-induced replicon initiation inhibition: no correlation with DDP-induced cytotoxicity. Mutat Res. 1984 Oct; 141(2):117-21. Ducore JM, Rosenstein BS. PMID: 6541756.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    67. Theophylline does not reverse DNA replicon initiation inhibition in human cells resistant to alkylating agent-theophylline killing synergism. Chem Biol Interact. 1984 Sep 15; 51(2):191-200. Ducore JM, Rosenstein BS. PMID: 6540627.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    68. Enhancement by bilirubin of DNA damage induced in human cells exposed to phototherapy light. Pediatr Res. 1984 Jan; 18(1):3-6. Rosenstein BS, Ducore JM. PMID: 6701032.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    69. Quantitative cell survival from growth curves following anti-neoplastic drug treatment. Mutat Res. 1983 Dec; 122(3-4):391-6. Ducore JM, Barth E. PMID: 6686284.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    70. The mechanism of bilirubin-photosensitized DNA strand breakage in human cells exposed to phototherapy light. Mutat Res. 1983 Dec; 112(6):397-406. Rosenstein BS, Ducore JM, Cummings SW. PMID: 6656800.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    71. Acute psychosis complicating induction therapy for acute lymphoblastic leukemia. J Pediatr. 1983 Sep; 103(3):477-80. Ducore JM, Waller DA, Emslie G, Bertolone SJ. PMID: 6577167.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    72. Induction of DNA strand breaks in normal human fibroblasts exposed to monochromatic ultraviolet and visible wavelengths in the 240-546 nm range. Photochem Photobiol. 1983 Jul; 38(1):51-5. Rosenstein BS, Ducore JM. PMID: 6622552.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    73. Effects of the epipodophyllotoxin VP-16-213 on cell cycle traverse, DNA synthesis, and DNA strand size in cultures of human leukemic lymphoblasts. Cancer Res. 1983 Apr; 43(4):1592-7. Kalwinsky DK, Look AT, Ducore J, Fridland A. PMID: 6572554.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    74. Comparative studies of DNA cross-linking and cytotoxicity in Burkitt's lymphoma cell lines treated with cis-diamminedichloroplatinum(II) and L-phenylalanine mustard. Cancer Res. 1982 Mar; 42(3):897-902. Ducore JM, Erickson LC, Zwelling LA, Laurent G, Kohn KW. PMID: 7199380.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    75. Differential cytotoxicity and DNA cross-linking in normal and transformed human fibroblasts treated with cis-diamminedichloroplatinum(II). Cancer Res. 1981 Jul; 41(7):2791-4. Erickson LC, Zwelling LA, Ducore JM, Sharkey NA, Kohn KW. PMID: 7195771.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    76. Regression on oxymetholone-induced hepatic tumors after bone marrow transplantation in aplastic anemia. Transplantation. 1980 Aug; 30(2):90-6. Montgomery RR, Ducore JM, Githens JH, August CS, Johnson ML. PMID: 7010713.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    77. DNA crosslinking and cytotoxicity in normal and transformed human cells treated with antitumor nitrosoureas. Proc Natl Acad Sci U S A. 1980 Jan; 77(1):467-71. Erickson LC, Bradley MO, Ducore JM, Ewig RA, Kohn KW. PMID: 6928639; PMCID: PMC348292.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    78. Multiple leukemic clones in acute leukemia of childhood. Hum Genet. 1978 Feb 16; 40(3):269-78. Morse HG, Ducore JM, Hays T, Peakman D, Robinson A. PMID: 273006.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    79. Letter: Thyroid carcinoma. N Engl J Med. 1976 Aug 05; 295(6):340-2. PMID: 934215.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    Jonathan's Networks
    Concepts (335)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (18)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UC Davis Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-4-g3cb31450 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California